The North America CRISPR and CRISPR-Associated (Cas) Genes Market is witnessing remarkable momentum as gene-editing technologies continue to reshape the future of healthcare, biotechnology, and life sciences. Driven by strong investments in genomic research, expanding applications in precision medicine, and the growing adoption of CRISPR-based therapeutics, the United States remains at the...